Remedium Lifecare [REMLIFE] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Remedium Lifecare

BSE
Loading...

Sun Pharma Advanced

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Remedium Lifecare wins in 8 metrics, Sun Pharma Advanced wins in 10 metrics, with 0 ties. Sun Pharma Advanced appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricRemedium LifecareSun Pharma AdvancedBetter
P/E Ratio (TTM)25.17-13.68Sun Pharma Advanced
Price-to-Book Ratio1.41-21.57Sun Pharma Advanced
Debt-to-Equity Ratio2,600.51-1.24Sun Pharma Advanced
PEG Ratio0.320.30Sun Pharma Advanced
EV/EBITDA3,209.73-17.40Sun Pharma Advanced
Profit Margin (TTM)1.17%-53.22%Remedium Lifecare
Operating Margin (TTM)1.65%-568.05%Remedium Lifecare
EBITDA Margin (TTM)1.65%N/AN/A
Return on Equity4.85%157.88%Sun Pharma Advanced
Return on Assets (TTM)0.12%-102.08%Remedium Lifecare
Free Cash Flow (TTM)$-11.44B$-3.71BSun Pharma Advanced
1-Year Return-83.46%-34.13%Sun Pharma Advanced
Price-to-Sales Ratio (TTM)0.3072.37Remedium Lifecare
Enterprise Value$12.80B$49.34BSun Pharma Advanced
EV/Revenue Ratio2.9076.39Remedium Lifecare
Gross Profit Margin (TTM)4.88%-10.68%Remedium Lifecare
Revenue per Share (TTM)$8$2Remedium Lifecare
Earnings per Share (Diluted)$0.06$-9.19Remedium Lifecare
Beta (Stock Volatility)1.200.30Sun Pharma Advanced
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Remedium Lifecare vs Sun Pharma Advanced Stock Performance Analysis

Loading Price Chart...

Remedium Lifecare
Sun Pharma Advanced
Remedium Lifecare Stock Overview | Sun Pharma Advanced Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Remedium Lifecare0.00%-1.32%14.50%57.89%-29.58%-70.41%
Sun Pharma Advanced-0.30%-0.46%0.18%-8.55%22.70%-28.31%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Remedium Lifecare-83.46%-98.90%-96.94%-96.94%-96.94%-96.94%
Sun Pharma Advanced-34.13%-33.75%-14.49%-62.56%59.18%-50.50%

News Based Sentiment: Remedium Lifecare vs Sun Pharma Advanced

Remedium Lifecare

News based Sentiment: POSITIVE

Remedium Lifecare experienced a significant month with a major contract win in the UK and approval for a substantial rights issue. These developments, coupled with positive Q1 FY26 results, suggest a potential turning point for the company and a strengthening investment case, despite some insider selling activity.

View Remedium Lifecare News Sentiment Analysis

Sun Pharma Advanced

News based Sentiment: MIXED

September brought a surprising analyst upgrade to 'Buy' with a massive price target for SPARC, despite the company continuing to report losses and declining revenue. This creates a mixed investment picture, with potential upside balanced against significant risks, making it a noteworthy month for investors.

View Sun Pharma Advanced News Sentiment Analysis

Performance & Financial Health Analysis: Remedium Lifecare vs Sun Pharma Advanced

MetricREMLIFESPARC
Market Information
Market Cap i₹1.33B₹46.74B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i13,810,708205,981
90 Day Avg. Volume i8,468,759222,297
Last Close₹1.50₹143.87
52 Week Range₹0.80 - ₹9.34₹109.30 - ₹241.00
% from 52W High-83.94%-40.30%
All-Time High₹4,547.80 (Jul 03, 2023)₹875.00 (Apr 24, 2006)
% from All-Time High-99.97%-83.56%
Growth Metrics
Quarterly Revenue Growth0.46%-0.43%
Quarterly Earnings Growth1.84%-0.43%
Financial Health
Profit Margin (TTM) i0.01%-0.53%
Operating Margin (TTM) i0.02%-5.68%
Return on Equity (TTM) i0.05%1.58%
Debt to Equity (MRQ) i2,600.51-1.24
Cash & Liquidity
Book Value per Share (MRQ)₹1.07₹-6.69
Cash per Share (MRQ)₹0.02₹0.06
Operating Cash Flow (TTM) i₹-16,381,918,000₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹21.29M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Remedium Lifecare vs Sun Pharma Advanced

MetricREMLIFESPARC
Price Ratios
P/E Ratio (TTM) i25.17-13.68
Forward P/E iN/A2.60
PEG Ratio i0.320.30
Price to Sales (TTM) i0.3072.37
Price to Book (MRQ) i1.41-21.57
Market Capitalization
Market Capitalization i₹1.33B₹46.74B
Enterprise Value i₹12.80B₹49.34B
Enterprise Value Metrics
Enterprise to Revenue i2.9076.39
Enterprise to EBITDA i3,209.73-17.40
Risk & Other Metrics
Beta i1.200.30
Book Value per Share (MRQ) i₹1.07₹-6.69

Financial Statements Comparison: Remedium Lifecare vs Sun Pharma Advanced

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)REMLIFESPARC
Revenue/Sales i₹1.13B₹96.40M
Cost of Goods Sold i₹1.08B₹106.70M
Gross Profit i₹55.35M₹-10.30M
Research & Development iN/AN/A
Operating Income (EBIT) i₹18.71M₹-547.60M
EBITDA i₹18.71M₹-429.40M
Pre-Tax Income i₹57.12M₹-518.10M
Income Tax i₹10.64M₹600,000
Net Income (Profit) i₹46.49M₹-518.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)REMLIFESPARC
Cash & Equivalents i₹2.82M₹19.64M
Total Current Assets i₹17.20B₹261.97M
Total Current Liabilities i₹16.76B₹3.74B
Long-Term Debt i₹0₹1.07B
Total Shareholders Equity i₹438.91M₹-2.17B
Retained Earnings iN/A₹-23.22B
Property, Plant & Equipment i₹83,000₹178.02M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)REMLIFESPARC
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricREMLIFESPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i13,810,708205,981
Average Daily Volume (90 Day) i8,468,759222,297
Shares Outstanding i577.65M324.52M
Float Shares i301.99M91.74M
% Held by Insiders i0.23%0.73%
% Held by Institutions i0.00%0.02%

Dividend Analysis & Yield Comparison: Remedium Lifecare vs Sun Pharma Advanced

MetricREMLIFESPARC
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A